Home / GLP-1 appeals / Mounjaro / Molina

Mounjaro denial · Molina

Molina denied your Mounjaro. Here is how to appeal it.

Many Molina Mounjaro denials are winnable, if your appeal answers the plan's own criteria and lands before the deadline. We draft it for free, grounded in your plan's actual coverage rules with every citation verified. You review, sign, and file it.

Free to draft. Every citation checked against your plan's policy before you file.

Your deadline

Often 60 days

For the internal appeal on Molina Medicaid plans, measured from the determination notice. Some states allow up to 180. Your notice controls, check it.

Most common reason

Off-label or step therapy

Mounjaro is approved for type 2 diabetes, so a weight-loss prescription, or a missing first-line trial, is a frequent denial trigger.

What wins

Filing at all

Molina has a low appeal rate and reverses a substantial share of the appeals it does receive. Most denials simply go unchallenged.

Why Molina denies Mounjaro

Mounjaro (tirzepatide) is FDA-approved to improve blood sugar in adults with type 2 diabetes. It is not FDA-approved for weight loss; that indication belongs to Zepbound, the same molecule under a different brand. That distinction drives most Molina denials:

  • Prescribed off-label for weight loss. When the records do not show a type 2 diabetes diagnosis, the plan reads the request as off-label and denies it. The first question to settle is which indication your prescription is actually for.
  • Step therapy or fail-first. Many plans require a documented trial of metformin or another preferred agent before Mounjaro. If your records do not show the trial or a reason you cannot take it, the claim is denied.
  • Formulary tier or quantity limit. The plan may prefer a different GLP-1 or cap the quantity. A denial here is about formulary placement, not whether the drug is appropriate for you.
  • Documentation gap read as medical necessity not met. Molina applies MCG criteria and denies when the records do not explicitly address a required element, so a gap on your diabetes history can read as a denial even when the diagnosis is clear in your chart.

How to win the appeal with Molina

The pattern that works against Molina is completeness: most denials are never appealed, and a large share that are get reversed. Anchor the appeal to the type 2 diabetes indication and close the documentation gap.

The move: establish the on-label use and answer the exact criterion. If Mounjaro is for type 2 diabetes, lead with the diagnosis, the A1c and labs, and the step-therapy history. Molina now discloses the specific MCG criterion behind a denial through its guideline-transparency tool, so you can answer the precise element that failed.

  • Document the diabetes diagnosis. Include the type 2 diabetes diagnosis, A1c and glucose labs, and the treatment history, so the on-label indication is unambiguous.
  • Clear the step-therapy hurdle. Show the trial of metformin or other preferred agents, or document the contraindication or intolerance that justifies skipping it.
  • File within the window. The internal appeal on Molina Medicaid plans is commonly 60 days from the determination notice, though some states allow up to 180. Submit a written authorized-representative designation if someone is appealing on your behalf, which Molina requires before it will begin processing.
  • Know the external step. After Molina's internal appeal, Medicaid members have the right to a state fair hearing, and marketplace members have the right to an independent external review.

Sources include your Molina plan's published coverage policy and the Mounjaro prescribing information. We cite the specific policy that applies to your plan when we build your appeal.

The magic is visible

Your appeal, built from your plan's own rules. Every citation checked.

We draft from the sources below, then verify each one before you file. On our held-out testing: 0 invented citations, versus about 1 in 4 for raw AI.

  • Molina's coverage policyThe Molina clinical policy and the specific MCG criterion cited in your denialVerified
  • FDA labelTirzepatide (Mounjaro) prescribing information, type 2 diabetes indication and dosingVerified
  • Your recordsYour type 2 diabetes diagnosis, A1c and labs, and prior diabetes therapies, cited back accuratelyVerified

Let's check your Molina denial, free.

Answer a few questions for an honest read on your odds, then your verified draft. No account, no cost.

Check my denial, free

Molina + Mounjaro: common questions

How long do I have to appeal?
On Molina Medicaid plans, the internal appeal is commonly 60 calendar days from the determination notice, though some states allow up to 180. Your denial notice states the deadline that applies to you, and that controls. File as early as you can.
I was prescribed Mounjaro for weight loss, can I still appeal?
You can, but it helps to understand the framing. Mounjaro is FDA-approved for type 2 diabetes, not weight loss. If you have type 2 diabetes, lead with that diagnosis. If the goal is weight management, Zepbound is the same molecule that is FDA-approved for it, and is often the stronger path. We will tell you honestly which fits your situation.
What if I have not tried metformin?
Step therapy can often be satisfied by documenting a contraindication, an intolerance, or a prior failure of the preferred agent. If none applies, the appeal is harder, and we will say so plainly.
Is this really free?
Yes. We draft your appeal for free and you file it. No fee, no contingency, nothing taken from coverage you win. AppealIt is not a law firm and does not provide legal or medical advice.

Other Mounjaro appeals: Centene · HCSC · Aetna · All Mounjaro denials